MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation
NYSE:MOH • US60855R1005
Current stock price
146.49 USD
-2.71 (-1.82%)
At close:
146.49 USD
0 (0%)
After Hours:
This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MOH Profitability Analysis
1.1 Basic Checks
- In the past year MOH was profitable.
- MOH had a negative operating cash flow in the past year.
- MOH had positive earnings in each of the past 5 years.
- Of the past 5 years MOH 4 years had a positive operating cash flow.
1.2 Ratios
- MOH's Return On Assets of 3.03% is fine compared to the rest of the industry. MOH outperforms 65.35% of its industry peers.
- MOH has a better Return On Equity (11.60%) than 78.22% of its industry peers.
- MOH's Return On Invested Capital of 7.39% is fine compared to the rest of the industry. MOH outperforms 70.30% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for MOH is significantly above the industry average of 8.92%.
- The 3 year average ROIC (14.32%) for MOH is well above the current ROIC(7.39%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROIC | 7.39% |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
1.3 Margins
- MOH has a Profit Margin (1.04%) which is in line with its industry peers.
- MOH's Profit Margin has declined in the last couple of years.
- MOH has a Operating Margin (1.73%) which is comparable to the rest of the industry.
- MOH's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 13.07%, MOH is doing worse than 67.33% of the companies in the same industry.
- MOH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% |
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
2. MOH Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MOH is creating some value.
- The number of shares outstanding for MOH has been reduced compared to 1 year ago.
- Compared to 5 years ago, MOH has less shares outstanding
- Compared to 1 year ago, MOH has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.20 indicates that MOH is not in any danger for bankruptcy at the moment.
- The Altman-Z score of MOH (4.20) is better than 78.22% of its industry peers.
- A Debt/Equity ratio of 0.97 indicates that MOH is somewhat dependend on debt financing.
- MOH's Debt to Equity ratio of 0.97 is in line compared to the rest of the industry. MOH outperforms 41.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.2 |
ROIC/WACC0.92
WACC7.99%
2.3 Liquidity
- A Current Ratio of 1.69 indicates that MOH should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.69, MOH is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
- MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
- MOH's Quick ratio of 1.69 is fine compared to the rest of the industry. MOH outperforms 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 |
3. MOH Growth Analysis
3.1 Past
- MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.98%.
- MOH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.02% yearly.
- MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.75%.
- MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.52% yearly.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
3.2 Future
- The Earnings Per Share is expected to grow by 21.69% on average over the next years. This is a very strong growth
- MOH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.17% yearly.
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. MOH Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 13.75 indicates a correct valuation of MOH.
- Compared to the rest of the industry, the Price/Earnings ratio of MOH indicates a rather cheap valuation: MOH is cheaper than 84.16% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.96, MOH is valued a bit cheaper.
- A Price/Forward Earnings ratio of 18.84 indicates a rather expensive valuation of MOH.
- Based on the Price/Forward Earnings ratio, MOH is valued a bit cheaper than 61.39% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, MOH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.75 | ||
| Fwd PE | 18.84 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -0.64 |
4.3 Compensation for Growth
- MOH's earnings are expected to grow with 13.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.58%
EPS Next 3Y13.62%
5. MOH Dividend Analysis
5.1 Amount
- MOH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MOH Fundamentals: All Metrics, Ratios and Statistics
146.49
-2.71 (-1.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)04-22 2026-04-22/amc
Inst Owners105.33%
Inst Owner Change-7.91%
Ins Owners1.33%
Ins Owner Change10.61%
Market Cap7.54B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target156.67 (6.95%)
Short Float %6.99%
Short Ratio1.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-12.12%
PT rev (3m)-10.16%
EPS NQ rev (1m)-29.32%
EPS NQ rev (3m)-38.77%
EPS NY rev (1m)-44.06%
EPS NY rev (3m)-42.68%
Revenue NQ rev (1m)-1.94%
Revenue NQ rev (3m)-5.23%
Revenue NY rev (1m)-4%
Revenue NY rev (3m)-4.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.75 | ||
| Fwd PE | 18.84 | ||
| P/S | 0.17 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.85 | ||
| P/tB | 4.03 | ||
| EV/EBITDA | -0.64 |
EPS(TTM)10.65
EY7.27%
EPS(NY)7.78
Fwd EY5.31%
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-10.39
OCFYN/A
SpS882.06
BVpS79.01
TBVpS36.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number137.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROCE | 9.57% | ||
| ROIC | 7.39% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% | ||
| FCFM | N/A |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.03 | ||
| Cap/Depr | 51.79% | ||
| Cap/Sales | 0.22% | ||
| Interest Coverage | 4.33 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.2 |
F-Score4
WACC7.99%
ROIC/WACC0.92
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A
MOLINA HEALTHCARE INC / MOH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 4 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 3 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Overvalued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 13.75 and the Price/Book (PB) ratio is 1.85.